Delivery Order SPE2DB22D3016-SPE2DB25FBFE3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,762.93 to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) on December 18, 2025, with completion targeted for December 19, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued to the pharmaceutical distributor's Corporate Office division headquartered in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $3,798.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) with a completion date of July 1, 2025. This non-set-aside contract represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a $6,890.00 delivery order to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) on September 3, 2025, with a completion date of September 4, 2025. This firm fixed-price delivery order represents a pediatric delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded with...
- The Defense Logistics Agency (DLA) awarded a $6,231.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of VEMLIDY 25 MG TABLET medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of...
- The Defense Logistics Agency awarded a $10,451.61 delivery order to AmerisourceBergen Drug Corp for VEMLIDY 25MG tablets (30-count package) under a firm fixed price contract with an ultimate completion date of January 15, 2026. This is a non-set-aside competitive award issued on December 17, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) has awarded a $10,445.23 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VEMLIDY 25 MG TABLET UU 30S. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The award, valued at $74,288.73, has a completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VEMLIDY 25 MG TABLET UU 30S. The $4,470.24 contract has a completion date of February 23, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,596.53 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of VEMLIDY 25 MG TABLET in 30-count units, with a completion date of February 13, 2024. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the...
- This federal contract award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,133.59 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024. The contract has an ultimate completion date of December 11, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBFE3Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,643.00 for VEMLIDY 25 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-competitive delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and reflects routine pharmaceutical procurement to support federal medical supply chain operations. This delivery order falls under AmerisourceBergen Drug Corp's substantial $999,999,999.00 indefinite delivery vehicle with DLA Troop Support Medical (designated SPE2DX) that extends through December 2026. As a major pharmaceutical distributor serving military and veteran healthcare systems, the company leverages this master contract to fulfill individual delivery orders for brand-name and generic medications across multiple therapeutic domains. The DLA Troop Support Medical supply chain utilizes such delivery orders to ensure consistent pharmaceutical availability for Defense Health Agency customers and other federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/15/25 |